Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sezzle Inc (SEZL) vs Zoetis Inc (ZTS) Price & Performance

Sezzle IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Sezzle Inc vs Zoetis Inc — how do they compare? Sezzle Inc trades at $128.64 (market cap $3.95B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 7.6× Sezzle Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sezzle Inc for 15 Days and Zoetis Inc for 70 Days on average.

SEZLZTS
Market Cap
$3.95B$30.20B
Volume
550,0756,175,327
Sector
FinancialsHealth
52-Week High
$188.55$147.53
52-Week Low
$50.97$69.09
Typical Hold Time
15 Days70 Days
Enterprise Value
$3.99B$37.76B
Dividend Yield
—2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sezzle Inc

SEZL stock is trading at $128.64, up 12.99% in the past 24 hours, showing strong momentum with a bullish technical signal. The company demonstrates exceptional profitability with 72.36% gross margins and 30.35% net income margins, while recent earnings have consistently beaten expectations. Analyst consensus remains strongly positive with a $168 price target representing significant upside potential from current levels.

SEZL presents a compelling growth opportunity with robust financial metrics and strong analyst support, though investors should monitor competitive pressures in the BNPL sector and the stock's current technical overbought conditions. The company's expanding product portfolio and subscriber growth provide fundamental support for continued appreciation.

Zoetis Inc

Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.

Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SEZL
33% Buy67% Sell
Avg holding period · 15 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Sezzle Inc

Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.

Read more on SEZL →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →